1. Nox4 has a crucial role in uric acid-induced oxidative stress and apoptosis in renal tubular cells
   Zhuohang Li et al, 2016 CrossRef
2. CD36 in chronic kidney disease: novel insights and therapeutic opportunities
   Xiaochun Yang et al, 2017, Nat Rev Nephrol CrossRef
3. Kidney as modulator and target of “good/bad” HDL
   Jianyong Zhong et al, 2018, Pediatr Nephrol CrossRef
4. Lipid Accumulation and Chronic Kidney Disease
   Zhibo Gai et al, 2019, Nutrients CrossRef
5. Pathophysiology of Progressive Renal Disease in Children
   H. William Schnaper, 2015 CrossRef
6. Pathophysiology of Progressive Renal Disease in Children
   H. William Schnaper, 2016 CrossRef
7. Lipid Metabolism Disorder and Renal Fibrosis
   Xiao-Gang Du et al, 2019 CrossRef
8. Influence of cellular lipid content on influenza A virus replication
   Nattavatchara Limsuwat et al, 2020, Arch Virol CrossRef
9. Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function Through Regulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in an Atherosclerosis Model
   Ze-Bing Zhu et al, 2020, Front. Pharmacol. CrossRef
10. The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
    Kamila Puchałowicz et al, 2020, Cells CrossRef
11. Association of high-density lipoprotein (HDL) cholesterol with GFR decline in a general nondiabetic population
    Toralf Melsom et al, 2021, Kidney International Reports CrossRef
12. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys
    Yanjuan Hou et al, 2021, Cell Death Dis CrossRef
13. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.
    Heidi Noels et al, 2021, Nat Rev Nephrol CrossRef
14. The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury
    Zhenzhen Li et al, 2021, Cell. Mol. Life Sci. CrossRef
15. High-Density Lipoproteins in Kidney Disease
    Valentina Kon et al, 2021, IJMS CrossRef
16. Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPARγ-dependent pathway.
    Tomohito Mizuno et al, 2022, J Biol Chem CrossRef
17. Association between lipid profile and residual renal function in incident peritoneal dialysis patients
    Yu Honda et al, 2022, Ther Apher Dial CrossRef
18. Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
    Luz M. González et al, 2022, Front. Pharmacol. CrossRef
19. Effect of Thymoquinone on Renal Damage Induced by Hyperlipidemia in LDL Receptor-Deficient (LDL-R-/-) Mice
    Wanjing Li et al, 2022, BioMed Research International CrossRef
20. Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?
    Konrad Zuzda et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
21. The Effect of Hyperlipidemia as a Risk Factor on Postoperative Complications in Patients Undergoing Anterior Cervical Discectomy and Fusion
    Seung Min Son et al, 2023 CrossRef
22. Post-translational modifications in kidney diseases and associated cardiovascular risk
    Heidi Noels et al, 2024, Nat Rev Nephrol CrossRef
23. Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations
    Lasin Ozbek et al, 2024, Medicina CrossRef
24. Age Differences in the Correlation Between the Cardiometabolic Index and Chronic Kidney Disease Risk in Adults With Hypertension
    Yu Tao et al, 2024, J of Clinical Hypertension CrossRef
25. Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy
    Danfeng Liu et al, 2024, Integr Med Nephrol Androl CrossRef